HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Learning To Drive The ‘Chariot’: FDA Deputy Califf’s New Role

This article was originally published in The Tan Sheet

Executive Summary

Renowned clinical trialist and cardiologist will become deputy commissioner for medical products and tobacco, a complicated and challenging position.

You may also be interested in...



Califf’s Trial Design Prescription: Less Randomization, More Transparency

FDA’s new deputy commissioner is expected to advocate for innovation in clinical studies; Duke cardiologist has led numerous trials, including pivotal Xarelto study and Vytorin outcomes trial.

FDA Lands Duke’s Califf As Top Deputy, Potential Next Commissioner

Renowned cardiologist and clinical trialist Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco.

‘Precision Medicine’ Gets R&D Funding Push In President’s Speech

President Obama highlights potential for personalized medicine in his State of the Union address and will seek a “major increase” in research and development funding.

Related Content

Topics

UsernamePublicRestriction

Register

RS123365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel